ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

GENE Genetic Technologies Ltd

2,44
0,00 (0,00%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:57:27
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 2,44 23:57:27
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,43 2,27 2,44 2,44 2,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202414:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
22.4.202421:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
18.4.202418:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17.4.202414:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16.4.202414:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11.4.202414:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08.4.202414:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02.4.202414:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26.3.202413:00GLOBEGTG Global Collaborations and Innovation Update
25.3.202413:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26.2.202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.2.202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.2.202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31.1.202414:00GLOBELaunching our most comprehensive test and expanding into new..
09.1.202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.1.202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.1.202414:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
05.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28.12.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.12.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.12.202323:00EDGAR2Form F-3 - Registration statement by foreign private issuers
14.12.202314:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12.12.202314:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30.10.202313:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18.10.202314:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27.9.202315:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12.9.202314:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11.9.202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.9.202314:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11.9.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.9.202316:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30.8.202314:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09.8.202314:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28.7.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.7.202314:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21.7.202314:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
23.5.202314:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock